Sign in
4

Changes in Ownership

Edesa Biotech, Inc. Filed Acc 0001171843-24-005045

Chief Executive Officer acquired 3,055 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Nijhawan Pardeep Chief Executive Officer 2024-09-03 Grant or award +3,055 129,318 D: show line 1 in the form
Loading xslF345X05/ownership.xml…